Transcriptomics

Dataset Information

0

SMPD4 mediated sphingolipid metabolism regulates brain and primary cilia development


ABSTRACT: SMPD4 (neutral sphingomyelinase-3/nSMase3) has recently been shown to be a new cause of microcephaly in a cohort of twenty-three pediatric patients. The function of nSMases in brain development and how SMPD4 variants cause human microcephaly and cerebellar hypoplasia was previously unknown.We developed an iPSC model to complement our mouse study. We found iPSC models from human SMPD4 patient and CRISPR/Cas9-induced SMPD4 knockout lines demonstrate a proliferation defect, increased cell death, loss of neural progenitors, and shortened primary cilia. Treatment with exogenous ceramide significantly rescues the cilia defect. SMPD4 patient and knockout cells have altered WNT signaling. We provide evidence that SMPD4 controls brain development by providing ceramide for primary ciliogenesis, suggesting a novel therapeutic strategy for SMPD4 mediated disease.

ORGANISM(S): Homo sapiens

PROVIDER: GSE250472 | GEO | 2023/12/24

REPOSITORIES: GEO

Similar Datasets

2023-07-12 | GSE228052 | GEO
2012-12-13 | E-GEOD-16696 | biostudies-arrayexpress
2021-05-26 | GSE175491 | GEO
2023-04-26 | GSE230552 | GEO
| PRJNA845213 | ENA
2022-07-28 | GSE209661 | GEO
2022-07-28 | GSE209660 | GEO
2022-07-28 | GSE209659 | GEO
2012-12-13 | GSE16696 | GEO
2008-09-15 | GSE12613 | GEO